← FDA Drug Approvals (Drugs@FDA)

POTASSIUM CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ANI PHARMS · Approved 2020-01-14

Drug application

FDA Application #

ANDA212779

Application type

Abbreviated New Drug Application (Generic)

Brand name

POTASSIUM CITRATE

Generic name

POTASSIUM CITRATE

Active ingredients

POTASSIUM CITRATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

ANI PHARMS

Manufacturer

ANI Pharmaceuticals, Inc.

First approval

2020-01-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown